Personal Resilience Empowerment Program Study



Status:Recruiting
Conditions:Lung Cancer, Liver Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Pancreatic Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:8/26/2018
Start Date:May 30, 2018
End Date:September 30, 2019
Contact:Marie Feiter
Email:Marie.Feiter@hackensackmeridian.org
Phone:732-450-2659

Use our guide to learn which trials are right for you!

Personal Resilience Empowerment Program (PREP) in the Perioperative Setting of Surgically Treated Cancer Patients

The Personal Resilience Empowerment Program (PREP) at Hackensack Meridian Integrative Health
& Medicine was designed in Legacy Meridian to assist all selected patients with upcoming
hospitalization. For the "Personal Resilience Empowerment Program (PREP) in the perioperative
setting of surgically treated cancer patients", hereafter "the Project or PREP", the
Hackensack Meridian Integrative Health & Medicine is designing a new pilot program to focus
on the needs of oncology patients.

All patients diagnosed with cancer that will undergo a scheduled surgical (Hepato-Biliary,
and Thoracic) procedure in Hackensack Meridian Health and specifically in the Jersey Shore
University Medical Center, will be eligible to participate (for more details please see
eligibility criteria, section 4).

Overall, this pilot project will include 5 coaching sessions and an introductory
session/visit that will take place on the physician's office. The initial physician visit
will focus on patient eligibility, introduction to the Project, informed consent and a
pre-intervention survey and will be conducted by the principal investigator or one of the
sub-investigators listed above. The following 5 sessions will be conducted by one of the
integrative health coaches/registered nurses (for details please see section 5). A
post-intervention survey will be completed during the final session and repeated at one
month, and at 3 months from the final session.

The goal of this project is to investigate whether using the PREP as an intervention in
patients diagnosed with cancer would result in improving various metrics including
improvements to resilience, sleep, activity, purpose, nutrition, empowerment to manage one's
own health and well-being, decrease in pain medication use and more rapid return to previous
functional status according to Eastern Cooperative Oncology Group (ECOG).


Inclusion Criteria:

- Patients diagnosed with cancer of the thoracic (lung), hepatobiliary system
(cholangiocarcinoma, pancreatic, liver) that will undergo a scheduled surgical
procedure

- Able to understand and sign the informed consent form

- Willingness to participate in the study and comply with protocol requirements

Exclusion Criteria:

- Unable to provide consent

- Unable to participate at the discretion of the PI based on the ECOG survey (if ECOG
>1). See section 5 and appendix 1 for details.

- Non- English speaking patients .

- Opioid use for non-malignant pain for greater than 7 days 6 Terminal or Stage 4
cancer.
We found this trial at
2
sites
Neptune, New Jersey 07753
Principal Investigator: Ronald Matteotti, MD
Phone: 732-450-2659
?
mi
from
Neptune, NJ
Click here to add this to my saved trials
Red Bank, New Jersey 07701
Phone: 732-450-2669
?
mi
from
Red Bank, NJ
Click here to add this to my saved trials